A high-quality, profitable business with growing sales. Insiders and institutions are both adding.
Facts from SEC filings, not a recommendation.
Latest insider buy: A director bought at $85.42 on Oct 1. The stock is now $80.61, -5.6% since.
From IBKR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $2.7B, up 22% from the 12 months before. Over 5 years, sales grew about 23% a year.
Move the sliders to your own view of IBKR. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
What today's price needs: with a 10% margin and a 32x P/E, sales would have to grow about 84% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: debt under half of equity. A checklist is a starting point for research, not a verdict.
Revenue and EPS as the company states them. Margins, cash flow and share count fill in with the 10-Q.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 2.1% to their holdings. 576 bought, 447 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Lori A ConklingDirector | Buy | 25 | $85.42 | $2K | 3K | Oct 1Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
25 shares at $85.42 · $2K
25 shares at $94.53 · $2K
25 shares at $87.03 · $2K
803,568 shares at $87.99 · $70.7M
25 shares at $88.03 · $2K
25 shares at $86.10 · $2K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page